Drug & Gene Delivery Systems Market Size, Share, Growth Report 2032
Drug & Gene Delivery Systems Market By Delivery System (Drug Delivery Systems, Gene Delivery Systems), By Route Of Administration (Oral, Ocular, Nasal, Injectable, Inhalation, Transdermal, Topical), By Application (Diabetes, Central Nervous System (CNS), Infectious Diseases, Oncology, Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2023 - 2030
Category: Biotechnology Report Format : PDF
Pages: 230 Report Code: ZMR-5831
Published Date: May-2023 Status : Published
| Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 483.9 Billion | USD 815.6 Billion | 7.33% | 2022 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Drug & Gene Delivery Systems Market, (2023 - 2030) (USD Billion)
- 2.2 Global Drug & Gene Delivery Systems Market : snapshot
- Chapter 3. Global Drug & Gene Delivery Systems Market - Industry Analysis
- 3.1 Drug & Gene Delivery Systems Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increase in the cases of chronic diseases among people across the globe to drive the industry growth
- 3.3 Market Restraints
- 3.3.1. Extortionate costs of development and tedious regulatory approvals might hinder the growth of the industry to an extent
- 3.4 Market Opportunities
- 3.4.1. Growing inclination toward personalized medicine creates ample opportunities for the industry
- 3.5 Market Challenges
- 3.5.1. Lack of standardization in drug delivery systems might act as a challenge for the industry
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Delivery System
- 3.7.2 Market attractiveness analysis By Route of Administration
- 3.7.3 Market attractiveness analysis By Application
- Chapter 4. Global Drug & Gene Delivery Systems Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Drug & Gene Delivery Systems Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Drug & Gene Delivery Systems Market - Delivery System Analysis
- 5.1 Global Drug & Gene Delivery Systems Market overview: By Delivery System
- 5.1.1 Global Drug & Gene Delivery Systems Market share, By Delivery System, 2022 and 2030
- 5.2 Drug Delivery Systems
- 5.2.1 Global Drug & Gene Delivery Systems Market by Drug Delivery Systems, 2023 - 2030 (USD Billion)
- 5.3 Gene Delivery Systems
- 5.3.1 Global Drug & Gene Delivery Systems Market by Gene Delivery Systems, 2023 - 2030 (USD Billion)
- 5.1 Global Drug & Gene Delivery Systems Market overview: By Delivery System
- Chapter 6. Global Drug & Gene Delivery Systems Market - Route of Administration Analysis
- 6.1 Global Drug & Gene Delivery Systems Market overview: By Route of Administration
- 6.1.1 Global Drug & Gene Delivery Systems Market share, By Route of Administration, 2022 and 2030
- 6.2 Oral
- 6.2.1 Global Drug & Gene Delivery Systems Market by Oral, 2023 - 2030 (USD Billion)
- 6.3 Ocular
- 6.3.1 Global Drug & Gene Delivery Systems Market by Ocular, 2023 - 2030 (USD Billion)
- 6.4 Nasal
- 6.4.1 Global Drug & Gene Delivery Systems Market by Nasal, 2023 - 2030 (USD Billion)
- 6.5 Injectable
- 6.5.1 Global Drug & Gene Delivery Systems Market by Injectable, 2023 - 2030 (USD Billion)
- 6.6 Inhalation
- 6.6.1 Global Drug & Gene Delivery Systems Market by Inhalation, 2023 - 2030 (USD Billion)
- 6.7 Transdermal
- 6.7.1 Global Drug & Gene Delivery Systems Market by Transdermal, 2023 - 2030 (USD Billion)
- 6.8 Topical
- 6.8.1 Global Drug & Gene Delivery Systems Market by Topical, 2023 - 2030 (USD Billion)
- 6.1 Global Drug & Gene Delivery Systems Market overview: By Route of Administration
- Chapter 7. Global Drug & Gene Delivery Systems Market - Application Analysis
- 7.1 Global Drug & Gene Delivery Systems Market overview: By Application
- 7.1.1 Global Drug & Gene Delivery Systems Market share, By Application, 2022 and 2030
- 7.2 Diabetes
- 7.2.1 Global Drug & Gene Delivery Systems Market by Diabetes, 2023 - 2030 (USD Billion)
- 7.3 CNS
- 7.3.1 Global Drug & Gene Delivery Systems Market by CNS, 2023 - 2030 (USD Billion)
- 7.4 Infectious Diseases
- 7.4.1 Global Drug & Gene Delivery Systems Market by Infectious Diseases, 2023 - 2030 (USD Billion)
- 7.5 Oncology
- 7.5.1 Global Drug & Gene Delivery Systems Market by Oncology, 2023 - 2030 (USD Billion)
- 7.6 Others
- 7.6.1 Global Drug & Gene Delivery Systems Market by Others, 2023 - 2030 (USD Billion)
- 7.1 Global Drug & Gene Delivery Systems Market overview: By Application
- Chapter 8. Drug & Gene Delivery Systems Market - Regional Analysis
- 8.1 Global Drug & Gene Delivery Systems Market Regional Overview
- 8.2 Global Drug & Gene Delivery Systems Market Share, by Region, 2022 & 2030 (USD Billion)
- 8.3. North America
- 8.3.1 North America Drug & Gene Delivery Systems Market, 2023 - 2030 (USD Billion)
- 8.3.1.1 North America Drug & Gene Delivery Systems Market, by Country, 2023 - 2030 (USD Billion)
- 8.3.1 North America Drug & Gene Delivery Systems Market, 2023 - 2030 (USD Billion)
- 8.4 North America Drug & Gene Delivery Systems Market, by Delivery System, 2023 - 2030
- 8.4.1 North America Drug & Gene Delivery Systems Market, by Delivery System, 2023 - 2030 (USD Billion)
- 8.5 North America Drug & Gene Delivery Systems Market, by Route of Administration, 2023 - 2030
- 8.5.1 North America Drug & Gene Delivery Systems Market, by Route of Administration, 2023 - 2030 (USD Billion)
- 8.6 North America Drug & Gene Delivery Systems Market, by Application, 2023 - 2030
- 8.6.1 North America Drug & Gene Delivery Systems Market, by Application, 2023 - 2030 (USD Billion)
- 8.4. Europe
- 8.4.2 Europe Drug & Gene Delivery Systems Market, 2023 - 2030 (USD Billion)
- 8.4.2.1 Europe Drug & Gene Delivery Systems Market, by Country, 2023 - 2030 (USD Billion)
- 8.4.2 Europe Drug & Gene Delivery Systems Market, 2023 - 2030 (USD Billion)
- 8.4 Europe Drug & Gene Delivery Systems Market, by Delivery System, 2023 - 2030
- 8.4.1 Europe Drug & Gene Delivery Systems Market, by Delivery System, 2023 - 2030 (USD Billion)
- 8.5 Europe Drug & Gene Delivery Systems Market, by Route of Administration, 2023 - 2030
- 8.5.1 Europe Drug & Gene Delivery Systems Market, by Route of Administration, 2023 - 2030 (USD Billion)
- 8.6 Europe Drug & Gene Delivery Systems Market, by Application, 2023 - 2030
- 8.6.1 Europe Drug & Gene Delivery Systems Market, by Application, 2023 - 2030 (USD Billion)
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific Drug & Gene Delivery Systems Market, 2023 - 2030 (USD Billion)
- 8.5.3.1 Asia Pacific Drug & Gene Delivery Systems Market, by Country, 2023 - 2030 (USD Billion)
- 8.5.3 Asia Pacific Drug & Gene Delivery Systems Market, 2023 - 2030 (USD Billion)
- 8.4 Asia Pacific Drug & Gene Delivery Systems Market, by Delivery System, 2023 - 2030
- 8.4.1 Asia Pacific Drug & Gene Delivery Systems Market, by Delivery System, 2023 - 2030 (USD Billion)
- 8.5 Asia Pacific Drug & Gene Delivery Systems Market, by Route of Administration, 2023 - 2030
- 8.5.1 Asia Pacific Drug & Gene Delivery Systems Market, by Route of Administration, 2023 - 2030 (USD Billion)
- 8.6 Asia Pacific Drug & Gene Delivery Systems Market, by Application, 2023 - 2030
- 8.6.1 Asia Pacific Drug & Gene Delivery Systems Market, by Application, 2023 - 2030 (USD Billion)
- 8.6. Latin America
- 8.6.4 Latin America Drug & Gene Delivery Systems Market, 2023 - 2030 (USD Billion)
- 8.6.4.1 Latin America Drug & Gene Delivery Systems Market, by Country, 2023 - 2030 (USD Billion)
- 8.6.4 Latin America Drug & Gene Delivery Systems Market, 2023 - 2030 (USD Billion)
- 8.4 Latin America Drug & Gene Delivery Systems Market, by Delivery System, 2023 - 2030
- 8.4.1 Latin America Drug & Gene Delivery Systems Market, by Delivery System, 2023 - 2030 (USD Billion)
- 8.5 Latin America Drug & Gene Delivery Systems Market, by Route of Administration, 2023 - 2030
- 8.5.1 Latin America Drug & Gene Delivery Systems Market, by Route of Administration, 2023 - 2030 (USD Billion)
- 8.6 Latin America Drug & Gene Delivery Systems Market, by Application, 2023 - 2030
- 8.6.1 Latin America Drug & Gene Delivery Systems Market, by Application, 2023 - 2030 (USD Billion)
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa Drug & Gene Delivery Systems Market, 2023 - 2030 (USD Billion)
- 8.7.5.1 The Middle-East and Africa Drug & Gene Delivery Systems Market, by Country, 2023 - 2030 (USD Billion)
- 8.7.5 The Middle-East and Africa Drug & Gene Delivery Systems Market, 2023 - 2030 (USD Billion)
- 8.4 The Middle-East and Africa Drug & Gene Delivery Systems Market, by Delivery System, 2023 - 2030
- 8.4.1 The Middle-East and Africa Drug & Gene Delivery Systems Market, by Delivery System, 2023 - 2030 (USD Billion)
- 8.5 The Middle-East and Africa Drug & Gene Delivery Systems Market, by Route of Administration, 2023 - 2030
- 8.5.1 The Middle-East and Africa Drug & Gene Delivery Systems Market, by Route of Administration, 2023 - 2030 (USD Billion)
- 8.6 The Middle-East and Africa Drug & Gene Delivery Systems Market, by Application, 2023 - 2030
- 8.6.1 The Middle-East and Africa Drug & Gene Delivery Systems Market, by Application, 2023 - 2030 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Pfizer
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Johnson & Johnson
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Novartis
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Roche
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Merck & Co.
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Sanofi
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 GlaxoSmithKline
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 AbbVie
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 AstraZeneca
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Bayer
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Bristol-Myers Squibb
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Celgene
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Amgen
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Biogen
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Gilead Sciences
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Illumina
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 Regeneron Pharmaceuticals
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Vertex Pharmaceuticals
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 Moderna
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 CRISPR Therapeutics
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 Among Others.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.1 Pfizer
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Drug & Gene Delivery Systems Market, 2023 - 2030 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Drug & Gene Delivery Systems Market attractiveness, By Delivery System
- 6. Global Drug & Gene Delivery Systems Market attractiveness, By Route of Administration
- 7. Global Drug & Gene Delivery Systems Market attractiveness, By Application
- 8. Global Drug & Gene Delivery Systems Market share by Delivery System, 2023 and 2030 (USD Billion)
- 9. Global Drug & Gene Delivery Systems Market by Drug Delivery Systems, 2023 - 2030 (USD Billion)
- 10. Global Drug & Gene Delivery Systems Market by Gene Delivery Systems, 2023 - 2030 (USD Billion)
- 11. Global Drug & Gene Delivery Systems Market share by Route of Administration, 2023 and 2030 (USD Billion)
- 12. Global Drug & Gene Delivery Systems Market by Oral, 2023 - 2030 (USD Billion)
- 13. Global Drug & Gene Delivery Systems Market by Ocular, 2023 - 2030 (USD Billion)
- 14. Global Drug & Gene Delivery Systems Market by Nasal, 2023 - 2030 (USD Billion)
- 15. Global Drug & Gene Delivery Systems Market by Injectable, 2023 - 2030 (USD Billion)
- 16. Global Drug & Gene Delivery Systems Market by Inhalation, 2023 - 2030 (USD Billion)
- 17. Global Drug & Gene Delivery Systems Market by Transdermal, 2023 - 2030 (USD Billion)
- 18. Global Drug & Gene Delivery Systems Market by Topical, 2023 - 2030 (USD Billion)
- 19. Global Drug & Gene Delivery Systems Market share by Application, 2023 and 2030 (USD Billion)
- 20. Global Drug & Gene Delivery Systems Market by Diabetes, 2023 - 2030 (USD Billion)
- 21. Global Drug & Gene Delivery Systems Market by CNS, 2023 - 2030 (USD Billion)
- 22. Global Drug & Gene Delivery Systems Market by Infectious Diseases, 2023 - 2030 (USD Billion)
- 23. Global Drug & Gene Delivery Systems Market by Oncology, 2023 - 2030 (USD Billion)
- 24. Global Drug & Gene Delivery Systems Market by Others, 2023 - 2030 (USD Billion)
- 25. Global Drug & Gene Delivery Systems Market share, by Region, 2023 and 2030
- 26. North America Drug & Gene Delivery Systems Market, 2023 - 2030 (USD Billion)
- 27. Europe Drug & Gene Delivery Systems Market, 2023 - 2030 (USD Billion)
- 28. Asia Pacific Drug & Gene Delivery Systems Market, 2023 - 2030 (USD Billion)
- 29. Latin America Drug & Gene Delivery Systems Market, 2023 - 2030 (USD Billion)
- 30. The Middle-East and Africa Drug & Gene Delivery Systems Market, 2023 - 2030 (USD Billion)
Table Of Tables
- 1. Global Drug & Gene Delivery Systems Market: Snapshot
- 2. Drivers of the Drug & Gene Delivery Systems Market: impact analysis
- 3. North America Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 4. North America Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 5. North America Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 6. U.S. Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 7. U.S. Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 8. U.S. Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 9. Canada Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 10. Canada Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 11. Canada Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 12. Europe Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 13. Europe Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 14. Europe Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 15. Germany Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 16. Germany Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 17. Germany Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 18. France Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 19. France Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 20. France Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 21. U.K. Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 22. U.K. Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 23. U.K. Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 24. Italy Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 25. Italy Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 26. Italy Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 27. Spain Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 28. Spain Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 29. Spain Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 30. Rest of Europe Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 31. Rest of Europe Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 32. Rest of Europe Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 33. Asia Pacific Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 34. Asia Pacific Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 35. Asia Pacific Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 36. China Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 37. China Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 38. China Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 39. Japan Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 40. Japan Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 41. Japan Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 42. India Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 43. India Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 44. India Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 45. South Korea Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 46. South Korea Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 47. South Korea Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 48. South-East Asia Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 49. South-East Asia Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 50. South-East Asia Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 51. Rest of Asia Pacific Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 52. Rest of Asia Pacific Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 53. Rest of Asia Pacific Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 54. Latin America Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 55. Latin America Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 56. Latin America Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 57. Brazil Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 58. Brazil Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 59. Brazil Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 60. Mexico Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 61. Mexico Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 62. Mexico Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 63. Rest of Latin America Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 64. Rest of Latin America Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 65. Rest of Latin America Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 66. The Middle-East and Africa Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 67. The Middle-East and Africa Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 68. The Middle-East and Africa Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 69. GCC Countries Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 70. GCC Countries Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 71. GCC Countries Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 72. South Africa Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 73. South Africa Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 74. South Africa Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
- 75. Rest of Middle-East Africa Drug & Gene Delivery Systems Market revenue, By Delivery System, 2023 - 2030 (USD Billion)
- 76. Rest of Middle-East Africa Drug & Gene Delivery Systems Market revenue, By Route of Administration, 2023 - 2030 (USD Billion)
- 77. Rest of Middle-East Africa Drug & Gene Delivery Systems Market revenue, By Application, 2023 - 2030 (USD Billion)
Methodology
FrequentlyAsked Questions
Drugs are the first-line treatment for nearly any minor or significant disease. The definition of drugs derives from the word drug delivery systems, which can be used to be a mechanism or a formulation that is used to introduce a medicinal agent into the body. This system or formulation helps to improve the potency of the medication within the body. A typical example can be a nasal spray, majorly used by people with nasal congestion. On the other hand, gene delivery mechanisms include the introduction of foreign genetic materials, DNA or RNA, into the host cell. In order for gene transmission to be successful, these foreign genetic materials should remain stable in the host cell, be incorporated into the genome, or be duplicated independently.
The global drug & gene delivery systems market is predicted to increase at a CAGR of 7.33% during the forecast period.
The global drug & gene delivery systems market was worth around USD 483.9 billion in 2022 and is expected to reach USD 815.6 billion by 2030.
The global drug & gene delivery systems market is being driven by several factors, including the increasing prevalence of chronic diseases, advancements in nanotechnology, and the growing demand for non-invasive drug delivery methods. Other drivers include the rise in biologics development and the increasing focus on personalized medicine.
North America held a notable share in the global drug & gene delivery systems market in 2022 and is likely to grow the fastest during the forecast period. The growth of the drug & gene delivery systems market in North America is being driven by factors such as development, a growing geriatric population, and favorable government policies supporting drug development. Additionally, the region has a strong presence of key market players, driving innovation and growth.
Some of the major companies operating in the drug & gene delivery systems market include Pfizer, Johnson & Johnson, Novartis, Roche, Merck & Co., Sanofi, GlaxoSmithKline, AbbVie, AstraZeneca, Bayer, Bristol-Myers Squibb, Celgene, Amgen, Biogen, Gilead Sciences, Illumina, Regeneron Pharmaceuticals, Vertex Pharmaceuticals, Moderna, and CRISPR Therapeutics.
Choose License Type
List of Contents
Drug Gene Delivery Systems Industry Perspective:Drug Gene Delivery Systems OverviewKey InsightsDrug Gene Delivery Systems Growth FactorsDrug Gene Delivery Systems RestraintsDrug Gene Delivery Systems OpportunitiesDrug Gene Delivery Systems ChallengesDrug Gene Delivery Systems SegmentationRecent Developments Drug Gene Delivery Systems Report ScopeDrug Gene Delivery Systems Regional AnalysisDrug Gene Delivery Systems Competitive PlayersRelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed